Pressure BioSciences, Inc. (PINK:PBIO) Promotes Itself To Little Effect

Last weekend, Pressure BioSciences, Inc. (PINK:PBIO), led by CEO Richard Schumacher, embarked on a self-promotional spree. Was it a shot in the dark or a well calculated move that was aimed at yielding some concrete results?

Typically, paid promotions are solely organized to give the stock in question a momentary boost so that the people paying for the effort get the chance to sell their stakes at high tide. More often than not, the initiators are outsiders. This time, however, the pump is carried out by PBIO‘s managers themselves.

Whatever the motif, though, the pump was a dismal failure. PBIO shares lost 3.85% on April 1 with barely 41,560 shares changing hands – not exactly what the guys at PBIO might have expected. It only takes a quick look at the company’s most recent SEC filings to understand why the company’s managers are so desperately trying to boost the market value of their stock.

As it is, the last majority of these filings are Form 4 statements designating changes in beneficial ownership of securities and the protagonists in these schemes are the managers themselves. Some of them acquired common stock, while others got stock options and warrants. And one needn’t go into detail to discern the managers’ desire to short their stakes at premium price levels which could be reached using the goold paid pumping approach.

Judging from the chart data, the promotional effort yielded less-than-stellar results. Of course, this does not necessarily mean that the campaign’s initators will not try again. On the contrary, such a prospect remains a possibility in the foreseeable future, which is why we would rather stay away from this stock until PBIO‘s managers figure out how to let real business be the driving force behind a possible chart expansion.